Clinical Trial Update: BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating combination therapy with BMS-986156, ipilimumab, and nivolumab, with or without stereotactic body radiation therapy, in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer
• Lung Cancer

Drugs mentioned

• BMS-986156
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Solid Neoplasm, Metastatic Carcinoma in the Liver | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-12-03